Navigation Links
Impact of New Drug Retail Prices Soon: Paswan

Consumers will feel the full impact of the new pricing regime for hundreds of generic drugs in a month when the current stocks with chemists were phased out//, Chemicals and Fertiliser Minister Ram Vilas Paswan said Tuesday.

"The agreement by the pharma industry to reduce the retail margin for generic and generic branded drugs has been implemented as scheduled on Oct 2 (Monday). The package of new pricing for around 1,000 drugs should have been implemented," Paswan told IANS.

"The full impact of the new pricing regime - with wholesale margins being kept at 15 percent and retail margins at 35 percent - will be felt in a month as we have agreed to give the pharma industry time till Nov 2 to phase out the current stocks with old minimum retail price (MRP) in retail outlets," he said.

The move to limit the margins at the wholesale and retail end has been worked out by the government and the industry as per the directive of the Supreme Court and is expected to make drugs more affordable, particularly for the poor.

Under the new regime, the MRP will be inclusive of the local taxes.

Effectively, the prices of hundreds of generic and branded generic drugs will be cheaper up to 80 percent in some cases.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Impact on Lung function based on exposure
2. Personality Impacts Arthritis
3. Support Services found to Dramatically Impact Pediatric Health Care
4. The Impact of Stress Early In Life
5. Environmental Factors Found To Have An Impact On The Sex of A Child
6. Environmental Factors Found To Have An Impact On The Sex of A Child
7. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
8. Earth Will Feel The Impact Of Global Warming
9. Obesity Has Adverse Impact On Breast Cancer Survival
10. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
11. Impact Of Late Motherhood on Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... 31, 2016 , ... The University of Tennessee Medical Center ... the latest in Clinical Patient Pod (CPP) technologies provided through Jvion’s ... into the clinical workflow. These insights are empowering the more than 30 case ...
(Date:5/31/2016)... Calif. (PRWEB) , ... May 31, 2016 , ... Effective ... colleagues, clients, and the industry as a whole. On June 2, Northbound CEO Mike ... on Addictive Disorders (WCSAD) and presenting the opening plenary on “Leadership: The Journey to ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... ... planetary and numeral energies can describe personality traits in humans. Using presidential candidate ... behind their name and vitality. , “AstroNumerology is not about adding numbers ...
(Date:5/31/2016)... ... ... TeaZa® Energy, LLC announces the launch of a new limited ... . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively online starting ... flavor is best described as a juicy, taste bud takeover. A mouthwatering wave ...
(Date:5/31/2016)... ... May 31, 2016 , ... To ... solutions to the healthcare industry, The University of Scranton is adding a Certificate ... path to a career in rapidly growing field of healthcare information. , ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... -- Since its commercial introduction in 2005, ... science tool for conducting genetic studies in a range ... its new report that the industry sits on the ... a range of new applications in the clinical diagnostics ... ) , Since the Human Genome ...
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
Breaking Medicine Technology: